Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Swislocki

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Journal of Human Hypertension|March 1, 1994
Impaired insulin clearance in essential hypertensionA L Swislocki
Diabetes Care|May 8, 1998
Case report. Pseudohepatotoxicity of metforminA L Swislocki, R Noth
JAMA|February 10, 1999
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention StudyD Siegel, A L Swislocki
The American Journal of Managed Care|March 22, 2001
Renal effects of angiotensin-converting enzyme inhibitors that result in cost savings and improved patient outcomesA L Swislocki, D Siegel
The American Journal of Medicine|March 3, 1991
Workshop III--Insulin resistance: is it truly the link?J L Izzo, A L Swislocki
The Western Journal of Medicine|March 1, 1991
CorrectionA L Swislocki, C A Camargo, A R Hoffman
American Journal of Hypertension|June 1, 1989
Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertensionA L Swislocki, B B Hoffman, G M Reaven
The Western Journal of Medicine|December 1, 1990
McCune-Albright syndrome. A case of primary hypogonadism obscured by hyperprolactinemic hypogonadotropic hypogonadismA L Swislocki, C A Camargo, A R Hoffman
Metabolism: Clinical and Experimental|July 1, 1987
Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individualsA Golay, A L Swislocki, Y D Chen, et al.
Clinical Nuclear Medicine|April 29, 1998
Hyperthyroidism: an underappreciated cause of diffuse bone diseaseA L Swislocki, C A Barnett, P Darnell, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Journal of Human Hypertension|March 1, 1994
Impaired insulin clearance in essential hypertensionA L Swislocki
Diabetes Care|May 8, 1998
Case report. Pseudohepatotoxicity of metforminA L Swislocki, R Noth
JAMA|February 10, 1999
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention StudyD Siegel, A L Swislocki
The American Journal of Managed Care|March 22, 2001
Renal effects of angiotensin-converting enzyme inhibitors that result in cost savings and improved patient outcomesA L Swislocki, D Siegel
The American Journal of Medicine|March 3, 1991
Workshop III--Insulin resistance: is it truly the link?J L Izzo, A L Swislocki
The Western Journal of Medicine|March 1, 1991
CorrectionA L Swislocki, C A Camargo, A R Hoffman
American Journal of Hypertension|June 1, 1989
Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertensionA L Swislocki, B B Hoffman, G M Reaven
The Western Journal of Medicine|December 1, 1990
McCune-Albright syndrome. A case of primary hypogonadism obscured by hyperprolactinemic hypogonadotropic hypogonadismA L Swislocki, C A Camargo, A R Hoffman
Metabolism: Clinical and Experimental|July 1, 1987
Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individualsA Golay, A L Swislocki, Y D Chen, et al.
Clinical Nuclear Medicine|April 29, 1998
Hyperthyroidism: an underappreciated cause of diffuse bone diseaseA L Swislocki, C A Barnett, P Darnell, et al.
Pageof 4